ArticleBlood and lymphatic cancer : targets and therapy2025

Venetoclax Plus Blinatumoma as First Line Therapy for Newly Diagnosed Ph-Negative B-Cell Acute Lymphoblastic Leukemia.

Yutian Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.